An estimated 15-20 per cent of children diagnosed with Dravets Syndrome die before reaching adulthood. There is no cure, and current treatment focuses on simply reducing seizures.
Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.